Now showing items 1-1 of 1

    • Dual-target-directed drugs that block monoamine oxidase B and adenosine A2A receptors for Parkinson’s disease 

      Petzer, Jacobus P.; Castagnoli, Neal; Schwarzschild, Michael A.; Chen, Jiang-Fan; Van der Schyf, Cornelis J.; Petzer, Jacobus P.; Castagnoli, Neal; Schwarzschild, Michael A.; Chen, Jiang-Fan; Van der Schyf, Cornelis J. (Springer, 2009)
      Inadequacies of the current pharmacotherapies to treat Parkinson’s disease (PD) have prompted efforts to identify novel drug targets. The adenosine A2A receptor is one such target. Antagonists of this receptor (A2A ...